TECX
Tectonic Therapeutic, Inc.
Price Chart
Latest Quote
$19.95
-0.12 (-0.60%)
Current Price
| Previous Close | $20.07 |
| Open | $20.00 |
| Day High | $20.52 |
| Day Low | $19.75 |
| Volume | 151,222 |
Stock Information
| Shares Outstanding | 19.55M |
| Total Debt | $4.40M |
| Cash Equivalents | $227.07M |
| Net Income | $-85.79M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $397.63M |
| EPS (TTM) | $-4.57 |
| Exchange | NGM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $167.34M |
| Income | $-85.79M |
| Book/sh | $11.64 |
| Cash/sh | $11.62 |
| Employees | 60 |
Financial Ratios
| Quick Ratio | 21.90 |
| Current Ratio | 22.29 |
| Debt/Eq | 1.97 |
Returns & Margins
| ROA | -22.29% |
| ROE | -33.80% |
Ownership
| Insider Ownership | 37.60% |
| Institutional Ownership | 71.98% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -4.28 |
| P/B | 1.75 |
Analyst Data
| Recommendation | strong_buy |
| Target Price | $71.00 |
Technical Indicators
| SMA20 | $21.78 |
| SMA50 | $26.99 |
| SMA200 | $28.08 |
| RSI | 34.09 |
| ATR | 1.1261 |
| Shares Float | 11.90M |
| Short Float | 22.99% |
| Short Ratio | 8.84 |
| Volatility | 0.38 |
| Rel Volume | 1.12 |
Performance History
| Week | -6.83% |
| Month | -13.48% |
| Quarter | -28.46% |
| 6 Months | -25.22% |
| YTD | -2.73% |
| Year | +18.60% |
| 3 Years | +8.65% |
| 5 Years | -70.11% |
| 10 Years | -94.57% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-10-27 | $20.34 | 226,968 |
| 2026-10-26 | $19.95 | 151,200 |
| 2026-10-23 | $20.07 | 145,000 |
| 2026-10-22 | $21.09 | 251,400 |
| 2026-10-21 | $21.84 | 152,800 |
| 2026-10-20 | $21.83 | 144,500 |
| 2026-10-19 | $21.15 | 203,000 |
| 2026-10-16 | $20.65 | 175,400 |
| 2026-10-15 | $21.30 | 187,400 |
| 2026-10-14 | $20.96 | 190,800 |
| 2026-10-13 | $21.31 | 164,000 |
| 2026-10-12 | $22.35 | 103,900 |
| 2026-10-09 | $23.33 | 110,700 |
| 2026-10-08 | $22.75 | 167,700 |
| 2026-10-07 | $22.71 | 300,800 |
| 2026-10-06 | $22.41 | 200,900 |
| 2026-10-05 | $23.11 | 312,600 |
| 2026-10-02 | $22.54 | 253,400 |
| 2026-10-01 | $22.67 | 343,500 |
| 2026-09-30 | $23.29 | 251,600 |
| 2026-09-29 | $23.34 | 1,050,100 |
| 2026-09-28 | $23.51 | 234,800 |
About Tectonic Therapeutic, Inc.
Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein coupled receptors (GPCRs). It develops GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company's lead product is TX45, a Fc-relaxin fusion molecule that activates the RXFP1 receptor, the GPCR target of the hormone, and relaxin. It is also developing TX2100 for the treatment of hereditary hemorrhagic telangiectasia; GPCR modulator bispecific for treating fibrosis; and other GPCR modulators. The company is headquartered in Watertown, Massachusetts.
đ° Latest News
No news articles available at the moment. Check back later for updates on TECX.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 | $0 |
| Expenses | ||||
| Interest Expense | $63,000 | $107,000 | $152,000 | $144,000 |
| Total Expenses | $84,036,000 | $58,015,000 | $44,648,000 | $32,830,000 |
| Other Income Expense | $-119,000 | $-4,121,000 | $1,396,000 | $645,000 |
| Other Non Operating Income Expenses | $-119,000 | $-511,000 | $141,000 | $2,000 |
| Net Non Operating Interest Income Expense | $11,234,000 | $4,154,000 | $429,000 | $5,000 |
| Interest Expense Non Operating | $63,000 | $107,000 | $152,000 | $144,000 |
| Operating Expense | $84,036,000 | $58,015,000 | $44,648,000 | $32,830,000 |
| General And Administrative Expense | $20,547,000 | $16,651,000 | $7,682,000 | $7,176,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-74,151,000 | $-57,982,000 | $-42,823,000 | $-32,180,000 |
| Net Interest Income | $11,234,000 | $4,154,000 | $429,000 | $5,000 |
| Interest Income | $11,297,000 | $4,261,000 | $581,000 | $149,000 |
| Normalized Income | $-74,151,000 | $-54,372,000 | $-44,078,000 | $-32,823,000 |
| Net Income From Continuing And Discontinued Operation | $-74,151,000 | $-57,982,000 | $-42,823,000 | $-32,180,000 |
| Total Operating Income As Reported | $-84,036,000 | $-58,015,000 | $-44,648,000 | $-32,830,000 |
| Net Income Common Stockholders | $-74,151,000 | $-57,982,000 | $-42,823,000 | $-32,180,000 |
| Net Income | $-74,151,000 | $-57,982,000 | $-42,823,000 | $-32,180,000 |
| Net Income Including Noncontrolling Interests | $-74,151,000 | $-57,982,000 | $-42,823,000 | $-32,180,000 |
| Net Income Continuous Operations | $-74,151,000 | $-57,982,000 | $-42,823,000 | $-32,180,000 |
| Pretax Income | $-72,921,000 | $-57,982,000 | $-42,823,000 | $-32,180,000 |
| Interest Income Non Operating | $11,297,000 | $4,261,000 | $581,000 | $149,000 |
| Operating Income | $-84,036,000 | $-58,015,000 | $-44,648,000 | $-32,830,000 |
| Per Share | ||||
| Diluted EPS | $-4.05 | $-6.83 | $-2.91 | $-2.18 |
| Basic EPS | $-4.05 | $-6.83 | $-2.91 | $-2.18 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-71,483,000 | $-52,620,000 | $-42,448,000 | $-31,673,000 |
| Reconciled Depreciation | $1,375,000 | $1,645,000 | $1,478,000 | $1,006,000 |
| EBITDA (Bullshit earnings) | $-71,483,000 | $-56,230,000 | $-41,193,000 | $-31,030,000 |
| EBIT | $-72,858,000 | $-57,875,000 | $-42,671,000 | $-32,036,000 |
| Diluted Average Shares | $18,322,533 | $8,490,171 | $14,734,323 | $14,734,323 |
| Basic Average Shares | $18,322,533 | $8,490,171 | $14,734,323 | $14,734,323 |
| Diluted NI Availto Com Stockholders | $-74,151,000 | $-57,982,000 | $-42,823,000 | $-32,180,000 |
| Tax Provision | $1,230,000 | $0 | - | - |
| Research And Development | $63,489,000 | $41,364,000 | $36,966,000 | $25,654,000 |
| Selling General And Administration | $20,547,000 | $16,651,000 | $7,682,000 | $7,176,000 |
| Other Gand A | $8,997,000 | $8,789,000 | $3,738,000 | $3,239,000 |
| Salaries And Wages | $11,550,000 | $7,862,000 | $3,944,000 | $3,937,000 |
| Total Unusual Items | - | $-3,610,000 | $1,255,000 | $643,000 |
| Total Unusual Items Excluding Goodwill | - | $-3,610,000 | $1,255,000 | $643,000 |
| Gain On Sale Of Security | - | $-3,610,000 | $1,255,000 | $643,000 |
Fetched: 2026-10-26
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $251,329,000 | $140,776,000 | $-84,636,000 | $-45,654,000 |
| Total Assets | $261,038,000 | $152,905,000 | $39,399,000 | $47,209,000 |
| Total Non Current Assets | $3,679,000 | $6,048,000 | $8,515,000 | $10,167,000 |
| Other Non Current Assets | $1,125,000 | $743,000 | $618,000 | $613,000 |
| Current Assets | $257,359,000 | $146,857,000 | $30,884,000 | $37,042,000 |
| Other Current Assets | $2,974,000 | $5,618,000 | $2,115,000 | $1,076,000 |
| Restricted Cash | $587,000 | $0 | - | - |
| Cash Cash Equivalents And Short Term Investments | $253,798,000 | $141,239,000 | $28,769,000 | $35,966,000 |
| Cash And Cash Equivalents | $253,798,000 | $141,239,000 | $28,769,000 | $35,966,000 |
| Non Current Deferred Assets | - | $0 | $669,000 | - |
| Debt | ||||
| Total Debt | $1,276,000 | $3,303,000 | $4,343,000 | $5,792,000 |
| Long Term Debt And Capital Lease Obligation | $43,000 | $519,000 | $2,520,000 | $4,343,000 |
| Current Debt And Capital Lease Obligation | $1,233,000 | $2,784,000 | $1,823,000 | $1,449,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $9,709,000 | $12,129,000 | $124,035,000 | $92,863,000 |
| Total Non Current Liabilities Net Minority Interest | $43,000 | $519,000 | $83,147,000 | $85,026,000 |
| Current Liabilities | $9,666,000 | $11,610,000 | $40,888,000 | $7,837,000 |
| Payables And Accrued Expenses | $4,323,000 | $5,241,000 | $5,694,000 | $3,731,000 |
| Payables | $1,093,000 | $976,000 | $409,000 | $574,000 |
| Accounts Payable | $1,093,000 | $976,000 | $409,000 | $574,000 |
| Other Current Liabilities | - | - | $30,515,000 | $499,000 |
| Other Non Current Liabilities | - | - | - | $56,000 |
| Non Current Deferred Liabilities | - | - | - | $0 |
| Current Deferred Liabilities | - | - | - | $0 |
| Equity | ||||
| Common Stock Equity | $251,329,000 | $140,776,000 | $-84,636,000 | $-45,654,000 |
| Total Equity Gross Minority Interest | $251,329,000 | $140,776,000 | $-84,636,000 | $-45,654,000 |
| Stockholders Equity | $251,329,000 | $140,776,000 | $-84,636,000 | $-45,654,000 |
| Gains Losses Not Affecting Retained Earnings | $-96,000 | $9,000 | $-11,000 | - |
| Other Equity Adjustments | $-96,000 | $9,000 | $-11,000 | - |
| Retained Earnings | $-222,737,000 | $-148,586,000 | $-90,604,000 | $-47,781,000 |
| Preferred Securities Outside Stock Equity | - | $0 | $80,627,000 | $80,627,000 |
| Other | ||||
| Ordinary Shares Number | $18,738,249 | $14,856,309 | $14,734,323 | $14,734,323 |
| Share Issued | $18,738,249 | $14,856,309 | $14,734,323 | $14,734,323 |
| Tangible Book Value | $251,329,000 | $140,776,000 | $-84,636,000 | $-45,654,000 |
| Invested Capital | $251,329,000 | $140,776,000 | $-84,636,000 | $-45,654,000 |
| Working Capital | $247,693,000 | $135,247,000 | $-10,004,000 | $29,205,000 |
| Capital Lease Obligations | $1,276,000 | $3,303,000 | $4,343,000 | $5,792,000 |
| Total Capitalization | $251,329,000 | $140,776,000 | $-84,636,000 | $-45,654,000 |
| Additional Paid In Capital | $474,160,000 | $289,351,000 | $5,979,000 | $2,127,000 |
| Capital Stock | $2,000 | $2,000 | $0 | $0 |
| Common Stock | $2,000 | $2,000 | $0 | $0 |
| Preferred Stock | $0 | $0 | $0 | - |
| Long Term Capital Lease Obligation | $43,000 | $519,000 | $2,520,000 | $4,343,000 |
| Current Capital Lease Obligation | $1,233,000 | $2,784,000 | $1,823,000 | $1,449,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $4,110,000 | $3,585,000 | $2,856,000 | $2,158,000 |
| Current Accrued Expenses | $3,230,000 | $4,265,000 | $5,285,000 | $3,157,000 |
| Net PPE | $2,554,000 | $5,305,000 | $7,228,000 | $9,554,000 |
| Accumulated Depreciation | $-3,407,000 | $-2,745,000 | $-1,856,000 | $-877,000 |
| Gross PPE | $5,961,000 | $8,050,000 | $9,084,000 | $10,431,000 |
| Leases | $25,000 | $25,000 | $25,000 | $25,000 |
| Other Properties | $5,655,000 | $7,744,000 | $8,616,000 | $9,964,000 |
| Machinery Furniture Equipment | $281,000 | $281,000 | $405,000 | $393,000 |
| Properties | $0 | $0 | $0 | $0 |
| Construction In Progress | - | $0 | $38,000 | $49,000 |
Fetched: 2026-10-26
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-60,286,000 | $-59,236,000 | $-40,960,000 | $-29,725,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-60,078,000 | $-59,080,000 | $-40,681,000 | $-27,637,000 |
| Cash Flow From Continuing Operating Activities | $-60,078,000 | $-59,080,000 | $-40,681,000 | $-27,637,000 |
| Operating Gains Losses | $153,000 | - | $264,000 | $-643,000 |
| Investing Activities | ||||
| Capital Expenditure | $-208,000 | $-156,000 | $-279,000 | $-2,088,000 |
| Investing Cash Flow | $-138,000 | $-156,000 | $-279,000 | $-2,088,000 |
| Cash Flow From Continuing Investing Activities | $-138,000 | $-156,000 | $-279,000 | $-2,088,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $173,098,000 | $94,600,000 | $34,125,000 | $38,017,000 |
| Financing Cash Flow | $173,355,000 | $171,714,000 | $33,747,000 | $37,628,000 |
| Cash Flow From Continuing Financing Activities | $173,355,000 | $171,714,000 | $33,747,000 | $37,628,000 |
| Net Other Financing Charges | $-485,000 | $75,965,000 | - | - |
| Net Common Stock Issuance | $173,098,000 | $94,600,000 | $34,125,000 | - |
| Common Stock Issuance | $173,098,000 | $94,600,000 | $34,125,000 | - |
| Net Preferred Stock Issuance | - | - | - | $38,017,000 |
| Preferred Stock Issuance | - | - | - | $38,017,000 |
| Other | ||||
| Repayment Of Debt | $-489,000 | $-475,000 | $-499,000 | $-393,000 |
| Interest Paid Supplemental Data | $63,000 | $107,000 | $152,000 | $144,000 |
| End Cash Position | $254,870,000 | $141,826,000 | $29,356,000 | $36,553,000 |
| Beginning Cash Position | $141,826,000 | $29,356,000 | $36,553,000 | $28,650,000 |
| Effect Of Exchange Rate Changes | $-95,000 | $-8,000 | $16,000 | - |
| Changes In Cash | $113,139,000 | $112,478,000 | $-7,213,000 | $7,903,000 |
| Proceeds From Stock Option Exercised | $1,231,000 | $1,624,000 | $121,000 | $4,000 |
| Net Issuance Payments Of Debt | $-489,000 | $-475,000 | $-499,000 | $-393,000 |
| Net Long Term Debt Issuance | $-489,000 | $-475,000 | $-499,000 | $-393,000 |
| Long Term Debt Payments | $-489,000 | $-475,000 | $-499,000 | $-393,000 |
| Net PPE Purchase And Sale | $-138,000 | $-156,000 | $-279,000 | $-2,088,000 |
| Sale Of PPE | $70,000 | $0 | - | - |
| Purchase Of PPE | $-208,000 | $-156,000 | $-279,000 | $-2,088,000 |
| Change In Working Capital | $-70,000 | $-10,278,000 | $-584,000 | $1,836,000 |
| Change In Other Current Liabilities | $-2,295,000 | $-565,000 | $-1,006,000 | $-1,049,000 |
| Change In Other Current Assets | $17,000 | $544,000 | $-5,000 | $-14,000 |
| Change In Payables And Accrued Expense | $-436,000 | $-7,063,000 | $1,446,000 | $3,275,000 |
| Change In Accrued Expense | $-552,000 | $-5,642,000 | $1,611,000 | $4,509,000 |
| Change In Payable | $116,000 | $-1,421,000 | $-165,000 | $-1,234,000 |
| Change In Account Payable | $116,000 | $-1,421,000 | $-165,000 | $-1,234,000 |
| Change In Prepaid Assets | $2,644,000 | $-3,194,000 | $-1,019,000 | $-376,000 |
| Other Non Cash Items | $2,118,000 | $4,044,000 | $-137,000 | $1,225,000 |
| Stock Based Compensation | $10,497,000 | $3,491,000 | $1,121,000 | $1,119,000 |
| Depreciation Amortization Depletion | $1,375,000 | $1,645,000 | $1,478,000 | $1,006,000 |
| Depreciation And Amortization | $1,375,000 | $1,645,000 | $1,478,000 | $1,006,000 |
| Gain Loss On Sale Of PPE | $153,000 | $0 | $9,000 | - |
| Net Income From Continuing Operations | $-74,151,000 | $-57,982,000 | $-42,823,000 | $-32,180,000 |
| Gain Loss On Sale Of Business | - | $0 | $255,000 | - |
| Issuance Of Debt | - | - | - | $0 |
| Long Term Debt Issuance | - | - | - | $0 |
| Gain Loss On Investment Securities | - | - | - | $-643,000 |
Fetched: 2026-10-26